AUSTIN, Texas--(BUSINESS WIRE)--
Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the second quarter of fiscal year 2019 ended December 31, 2018.
The second quarter was a pivotal quarter for Astrotech’s 1st Detect subsidiary, which announced on December 12, 2018 that its TRACER 1000 passed the rigorous European Civil Aviation Conference (ECAC) Common Evaluation Process (CEP) tests for airport checkpoint screening of passengers. Subsequent to the quarter-end, on January 7, 2019, the Company announced that the TRACER 1000 also passed the CEP tests for airport cargo screening. Official ECAC Certification is expected in the near-term, at which point, the Company can begin selling the TRACER 1000 to international airports.
“We are excited to have introduced our revolutionary new product, the TRACER 1000, this quarter as the best solution available to overcome the high false alarm problems with the currently used ion mobility spectrometry technology. Our mass spectrometry technology delivers a valuable near-zero false alarm rate that has the potential to earn airports and airlines hundreds of millions in worldwide savings while making airways safer and moving passengers through the security lanes more efficiently,” stated Thomas B. Pickens III, Chairman and CEO of Astrotech.
Second Quarter Fiscal Year 2019 Financial Highlights
Management continues efforts to optimize our resources while reducing cost and adding financial flexibility.
- Operating expenses decreased $1.0 million, or 31%, during the second quarter of fiscal 2019, compared to the second quarter of fiscal 2018, due to an ongoing emphasis on cost reduction.
- Our monthly cash burn for this quarter was reduced to $705 thousand, a 22% reduction from our run rate in fiscal year 2018.
- On October 9, 2018, Astrotech completed a $3 million private investment from its Chairman and CEO and another long-term investor.
- Astrotech Corporation had no debt at December 31, 2018.
About Astrotech
Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. 1st Detect develops, manufactures, and sells chemical analyzers for use in the security, defense, healthcare, and environmental markets. Astral Images sells film-to-digital image enhancement, defect removal, color correction, and post processing software, providing economically feasible conversion of film to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format. Astrotech is headquartered in Austin, Texas. For information, please visit .
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the Company’s use of proceeds from the private placement transaction, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K for the fiscal year ended June 30, 2018. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements.
| ASTROTECH CORPORATION AND SUBSIDIARIES | |||||||||||||||||||||
| Condensed Consolidated Statements of Operations and Comprehensive Loss | |||||||||||||||||||||
|
(In thousands, except per share data) |
|||||||||||||||||||||
|
(Unaudited) |
|||||||||||||||||||||
|
Three Months Ended |
Six Months Ended |
||||||||||||||||||||
| 2018 | 2017 | 2018 | 2017 | ||||||||||||||||||
| Revenue | $ | 7 | $ | 41 | $ | 40 | $ | 41 | |||||||||||||
| Cost of revenue | — | 24 | 11 | 24 | |||||||||||||||||
| Gross profit | 7 | 17 | 29 | 17 | |||||||||||||||||
| Operating expenses: | |||||||||||||||||||||
| Selling, general and administrative | 1,286 | 1,602 | 2,430 | 3,034 | |||||||||||||||||
| Research and development | 897 | 1,582 | 2,000 | 3,226 | |||||||||||||||||
| Total operating expenses | 2,183 | 3,184 | 4,430 | 6,260 | |||||||||||||||||
| Loss from operations | (2,176 | ) | (3,167 | ) | (4,401 | ) | (6,243 | ) | |||||||||||||
| Interest and other income, net | 16 | 30 | 3 | 100 | |||||||||||||||||
| Loss before income taxes | (2,160 | ) | (3,137 | ) | (4,398 | ) | (6,143 | ) | |||||||||||||
| Income tax benefit | — | — | — | — | |||||||||||||||||
| Net loss | $ | (2,160 | ) | $ | (3,137 | ) | $ | (4,398 | ) | $ | (6,143 | ) | |||||||||
| Weighted average common shares outstanding: | |||||||||||||||||||||
| Basic and diluted | 4,678 | 4,060 | 4,374 | 4,059 | |||||||||||||||||
| Basic and diluted net loss per common share: | |||||||||||||||||||||
| Net loss | $ | (0.46 | ) | $ | (0.77 | ) | $ | (1.01 | ) | $ | (1.51 | ) | |||||||||
| Other comprehensive loss, net of tax: | |||||||||||||||||||||
| Net loss | $ | (2,160 | ) | $ | (3,137 | ) | $ | (4,398 | ) | $ | (6,143 | ) | |||||||||
| Available-for-sale securities: | |||||||||||||||||||||
| Net unrealized gain | — | (36 | ) | — | (35 | ) | |||||||||||||||
| Reclassification adjustment for realized loss | — | 33 | 31 | 34 | |||||||||||||||||
| Total comprehensive loss | $ | (2,160 | ) | $ | (3,140 | ) | $ | (4,367 | ) | $ | (6,144 | ) | |||||||||
| ASTROTECH CORPORATION AND SUBSIDIARIES | ||||||||||
| Condensed Consolidated Balance Sheets | ||||||||||
|
(In thousands, except share data) |
||||||||||
|
(Unaudited) |
||||||||||
|
December 31, |
June 30, |
|||||||||
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | $ | 2,846 | $ | 552 | ||||||
| Short-term investments | — | 3,551 | ||||||||
| Accounts receivable, net of allowance | 8 | 12 | ||||||||
| Prepaid expenses and other current assets | 236 | 161 | ||||||||
| Total current assets | 3,090 | 4,276 | ||||||||
| Property and equipment, net | 595 | 733 | ||||||||
| Long-term investments | — | 50 | ||||||||
| Other assets, net | 81 | 81 | ||||||||
| Total assets | $ | 3,766 | $ | 5,140 | ||||||
| Liabilities and stockholders’ equity | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | $ | 219 | $ | 112 | ||||||
| Payroll-related accruals | 392 | 412 | ||||||||
| Accrued liabilities and other | 336 | 434 | ||||||||
| Income tax payable | 2 | 2 | ||||||||
| Total current liabilities | 949 | 960 | ||||||||
| Other liabilities | 167 | 188 | ||||||||
| Total liabilities | 1,116 | 1,148 | ||||||||
| Commitments and contingencies | ||||||||||
| Stockholders’ equity | ||||||||||
| Preferred stock, $0.001 par value, convertible, 2,500,000 shares authorized; no shares issued and outstanding at December 31, 2018 and June 30, 2018, respectively | — | — | ||||||||
| Common stock, $0.001 par value, 15,000,000 shares authorized; 5,970,885 and 4,496,873 shares issued at December 31, 2018 and June 30, 2018, respectively; 5,570,969 and 4,097,346 shares outstanding at December 31, 2018 and June 30, 2018, respectively | 190,584 | 190,570 | ||||||||
| Treasury stock, 399,916 and 399,527 shares at cost at December 31, 2018 and June 30, 2018, respectively | (4,129 | ) | (4,128 | ) | ||||||
| Additional paid-in capital | 4,757 | 1,745 | ||||||||
| Accumulated deficit | (188,562 | ) | (184,164 | ) | ||||||
| Accumulated other comprehensive loss | — | (31 | ) | |||||||
| Total stockholders’ equity | 2,650 | 3,992 | ||||||||
| Total liabilities and stockholders’ equity | $ | 3,766 | $ | 5,140 | ||||||
View source version on businesswire.com:
